Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, July 13, 2015, 31 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $96.20 to $140,810,972.40.

Highlighted Stocks Traded by Insiders:

Omnicell (OMCL) - FREE Research Report

Petersmeyer Gary S, who is Director at Omnicell, sold 670 shares at $39.32 on July 13, 2015. Following this transaction, the Director owned 18,227 shares meaning that the stake was reduced by 3.55% with the 670-share transaction.

The shares most recently traded at $39.57, up $0.25, or 0.63% since the insider transaction. Historical insider transactions for Omnicell go as follows:

  • 4-Week # shares sold: 4,067
  • 12-Week # shares sold: 25,645
  • 24-Week # shares sold: 27,655

The average volume for Omnicell has been 181,800 shares per day over the past 30 days. Omnicell has a market cap of $1.4 billion and is part of the technology sector and computer software & services industry. Shares are up 19.41% year-to-date as of the close of trading on Monday.

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates in two segments, Automation and Analytics, and Medication Adherence. The company has a P/E ratio of 47.3. Currently, there are 4 analysts who rate Omnicell a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OMCL - FREE

TheStreet Quant Ratings

rates Omnicell as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full

Omnicell Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Village Super Market (VLGEA) - FREE Research Report

Estate of Perry Sumas, who is Shareholder at Village Super Market, sold 6,685 shares at $32.04 on July 13, 2015. Following this transaction, the Shareholder owned 928,980 shares meaning that the stake was reduced by 0.71% with the 6,685-share transaction.

The shares most recently traded at $31.87, down $0.17, or 0.53% since the insider transaction. Historical insider transactions for Village Super Market go as follows:

  • 4-Week # shares sold: 10,858
  • 12-Week # shares sold: 66,698
  • 24-Week # shares sold: 244,499

The average volume for Village Super Market has been 31,600 shares per day over the past 30 days. Village Super Market has a market cap of $312.9 million and is part of the services sector and retail industry. Shares are up 17.17% year-to-date as of the close of trading on Monday.

Village Super Market, Inc., together with its subsidiaries, operates a chain of supermarkets in the United States. The stock currently has a dividend yield of 3.13%. The company has a P/E ratio of 15.2. Currently, there are no analysts who rate Village Super Market a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VLGEA - FREE

TheStreet Quant Ratings

rates Village Super Market as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, compelling growth in net income, attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Village Super Market Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

State Auto Financial (STFC) - FREE Research Report

State Automobile Mutual Insurance Co, who is 10% Owner at State Auto Financial, bought 2,500 shares at $25.61 on July 13, 2015. Following this transaction, the 10% Owner owned 25.9 million shares meaning that the stake was boosted by 0.01% with the 2,500-share transaction.

The shares most recently traded at $25.98, up $0.37, or 1.43% since the insider transaction. Historical insider transactions for State Auto Financial go as follows:

  • 4-Week # shares bought: 19,188
  • 12-Week # shares bought: 65,201
  • 24-Week # shares bought: 238,588

The average volume for State Auto Financial has been 37,200 shares per day over the past 30 days. State Auto Financial has a market cap of $1.1 billion and is part of the financial sector and insurance industry. Shares are up 17.73% year-to-date as of the close of trading on Monday.

State Auto Financial Corporation, through its subsidiaries, engages in writing personal, business, and specialty insurance products. It operates through four segments: Personal insurance, Business insurance, Specialty insurance, and Investment operations. The stock currently has a dividend yield of 1.56%. The company has a P/E ratio of 10.1. Currently, there is 1 analyst who rates State Auto Financial a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on STFC - FREE

TheStreet Quant Ratings

rates State Auto Financial as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

State Auto Financial Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.